Clinical performance of decellularized heart valves versus standard tissue conduits: a systematic review and meta-analysis

Table 4 Decellularized heart valve characteristics in eligible full-text articles

Authors	Donor species	Donor tissue/valve type	Recipient species	Recipient site	Number of patients
Bechtel et al. 2005^a [39]	Human	PV	Human	RVOT	22
Bechtel et al. 2008^a [40]	Human	PV	Human	RVOT	23
Bibevski et al. 2017^a [41]	Human	PV	Human	RVOT	163
Boethig et al. 2019 [42]	Human	PV	Human	RVOT	235
Brown et al. 2010^a [43]	Human	PV	Human	RVOT	342
Brown et al. 2011^a [44]	Human	PV	Human	RVOT	29
Burch et al. 2010^a [45]	Human	PV	Human	RVOT	47
Cebotari et al. 2011 [46]	Human	PV	Human	RVOT	38
da Costa et al. 2005 [47]	Human	PV	Human	RVOT	11
da Costa et al. 2007^b [33]	Human	PV	Human	RVOT	68
da Costa et al. 2018^c [48]	Human	PV	Human	RVOT	94
Etnel et al. 2018^c [49]	Human	PV	Human	RVOT	130
Konuma et al. 2009^a [50]	Human	PV	Human	RVOT	41
Ruzmetov et al. 2012 [51]	Human	PV	Human	RVOT	39
Sarikouch et al. 2016 [34]	Human	PV	Human	RVOT	93
Sievers et al. 2003 [52]	Human	PV	Human	RVOT	17
Tavakkol et al. 2005^a [53]	Human	PV	Human	RVOT	26

PV pulmonary valve, RVOT right ventricular outflow tract
^aCryoValve SynerGraft (CryoLife Inc., Kennesaw, Georgia, US) pulmonary homograft
^bPulmonary homografts were provided by the Human Heart Valve Bank (Hospital Santa Casa de Misericórdia, Curitiba, BR)
^cPulmonary homografts were obtained at the Multi-Tissue Bank (Pontifical Catholic University of Paraná, Curitiba Campus, Curitiba, BR)

ISSN: 1749-8090